chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed headaches, vision loss and eye pain. 5Dec03: Received anthrax #1, Twinrix and Influenza vaccines. 13Dec03: noticed fluid filled lesion on forefoot and a similar swelling under tongue that sometimes impaired speech. 20Dec03: Developed photophobia and throbbing headaches everywhere in head. He took Tylenol, continued full duty and did not seek medical care. He had sinus congestion at the time and these symptoms were related. 22Dec03: Awakened with headache and vision loss in right eye. Experienced aching in the eyeball itself and had acute pain in right eye when moving it. Pt was went to med center on 23Dec03 and was admitted to the inpatient service for an expedited malignancy workup. Diagnosis: right subretinal growth, likely idiopathic granuloma. Work up proved negative except for evidence of old granulomatous growth found on CT of the chest. He was also evaluated in ENT and the sulingual lesion was diagnosed as a mucocele and the lesion on the foot as a ganglionic cyst. He was started on prednisone 20mg and sent on CVL. Ophthalmology expected that his eye improve enough (if not fully) such that he will be a deployable soldier in the next 6-12 months. He continued on the prednisone for 3 weeks and his right vision improved so that he could see shapes but not details or colors. He followed up regularly with providers near his home. An MRI of the brain in Jun2004 showed Patchy white matter lesions possibly demyelinating or related to Leukoencephalopathy. Daily headaches have continued until the present. There is no pattern to them and some episodes are more severe than others. In Feb05 he returned to med center for further medical evaluation. This evaluation continues to the present.
I've saw this pt for sx poss r/t the flu shot from yesterday: Received Flu shot 10/06.  Few hours later (4 hours?)felt her throat was closing up and had difficulty swallowing and blurry vision.  Took Mylanta thinking it might be reflux.  also took a benadryl.  Woke up this am with bilat conjunctival injection and eyes and lips were "puffy"  Intestinal cramping last night.  Puffiness has resolved on own.  Conjunctival  injection and sense of "heavy" throat remains.  Had some SOB this AM going up stairs. Had reaction to flu shot 2 years ago with sense that throat was closing but thought it was all in her mind.  Skipped last year flu shot but got "the flu" so wanted to try it again this year. NKDA or sensitivities.  Hx mild psoriasis or eczema-- so does dad.  Her dad also had an anaphylactic reaction to "something, but not a vaccine" few years ago- recovered.  Denies f/c/s, recent URI or any illness, hives, rash, syncope, palpitations, or chest pain.  Can swallow now.  EXAM: 139/80, 80, 16, 98.9, LNMP 10/07/08.  Derm:  No hives, rash, skin w % d, good color, Eyes: No periorbital edema.  Bilat conjunctival injection, no tearing, no d/c.  Mouth:  no angioedema  Throat:  post pharnx pink, no swelling, uvula with symmetrical rise.  small amt of pnd.  No stridor with throat auscultation.  Lungs CTA, unlabored, symmetrical rise CV: Normal S1, S2 no m/r/g, RRR
Sore arm lasting several weeks. After the  first done (June 15, 2021), could not move arm for a couple of days and arm was sore at the injection site. After about 3 days, it was no longer sore  at the injection site, but could not lift arm higher than shoulder height without it hurting. This was still occurring when  visiting to receive the second dose (21 days later on July 6, 2021). Immediately following the injection, could not lift arm at all for about 2-3 days without being in excruciating pain. After about 3 days, I could raise arm, but again, it hurts to raise it any higher than shoulder height. This is now a week after the 2nd shot, and it still hurts and seem to have limited mobility without it hurting. I  can raise arm higher than shoulder height, but it causes immense pain when doing so.
Information has been received from a physician assistant concerning a 23 year old female patient with hypothyroidism who on 23-SEP-2009 was vaccinated with a dose of MMR II, 0.5 ml SC in upper right arm, (Lot # 663524/1727X).  Concomitant therapy included levothyroxine Na.  On 23-SEP-2009 night after receiving the vaccine, the patient's arm was tingling at the injection site and she was experiencing burning across the chest and shortness of breath.  Patient was seen for follow up on 24-SEP-2009 and she stated that she was experiencing decreased appetite, abdominal cramping and shortness of breath.  Injection site tingling was better but client was "still feeling crummy".  Physician assistant stated patient's peak flow measures were within normal limits.  At the time of the report, the patient's AE did not improve.  Additional information has been requested.
Bell's palsy; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced bell's palsy on an unspecified date with outcome of unknown.  Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Experienced severe chills for several hours; not mitigated by 1/2-hr hot bath followed by bed with electrie blanket & heating pad.  stopped shaking about 1 AM. Next morning still felt extremely week & lethargic; continued until about 6pm on day followng shot (approx 24 hr duration)
Injection site felt like a strong punch to the arm; like a flu shot immediately after the injection but soon feeling much more painful than a flu shot. Within 6 to 8 hours, body aches. Within about 16 hours, flu-like symptoms of body ache, cold-then-hot, fatigue. Within 24 hours, full flu-like symptoms including skin sensitivity to touch, even hair on scalp. By about 40 hours, flu like symptoms gone but arm soreness at the injection site remained for 5 or 6 days. Only one ibuprofen taken at the worst of the flu symptoms. Never had had this strong a reaction to an immunization before. Going in for the 2nd shot in the series in the next week or so. Side effects from that one should be interesting.
JOINT PAIN IN BOTH LEGS AND SHOULDERS; MUSCLE PAIN IN BOTH LEGS AND SHOULDERS; This spontaneous report received from a consumer concerned a 47 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced joint pain in both legs and shoulders, and muscle pain in both legs and shoulders. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle pain in legs and shoulders and joint pain in legs and shoulders was not reported. This report was non-serious. This case, from the same reporter is linked to 20211240211, 20211240486, 20211240436 and 20211241144.
Feeling crappy / Feeling miserable; Can barely move; Headache; Feeling / achy; Feeling / nauseous; Her right arm hurts; This case was reported by a consumer via call center representative and described the occurrence of feels awful in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included dental cleaning. Previously administered products included Shingrix (Patient received 1st dose of shingrix on an unknown date.).   On 15th February 2021 04:00, the patient received the 2nd dose of Shingrix (intramuscular). On 16th February 2021, 1 days after receiving Shingrix, the patient experienced feels awful, mobility decreased, headache, pain, nausea and pain in arm. On an unknown date, the outcome of the feels awful, mobility decreased, headache, pain, nausea and pain in arm were not recovered/not resolved.   The reporter considered the feels awful, mobility decreased, headache, pain, nausea and pain in arm to be possibly related to Shingrix.  Additional details provided as follow: The patient reported case for herself. The reporter was asking if it was okay if she went to her dental cleaning on ay of reporting. She said that this was type of dental cleaning was a deep gum dental cleaning. It was given every 5 years where they numb everything and go deep down under the gums. Because she had metal in her neck she was pretreated with antibiotics prior to today's dental appointment. The patient received the injection intramuscularly at the pharmacy on day before reporting in the right deltoid. Th patient did not have the lot number or expiration date but did provide her pharmacy's phone number. The patient's symptoms included, she could barely move, headache, feeling miserable, achy and nauseous. She also said her right arm hurts; the arm where she received the injection. These events did not resolved. The reporter does felt these events are related to the Shingrix because she said she never feels this way. (She said she did not remember the first Shingrix shot bothering her). The reporter requesting consent to follow up.
Child treated by PCP for episode of diarrhea lasting > 4 days which produced hemoccult positive stool result.  PCP treated with Pedialyte & placed formula feed on hold.  Desitin to rash.
On 3/2/00 the pt contracted a severe case of poison ivy, which was treated with prednisone. On 9/1/00 she was found to be seronegative. No treatment was given. As of 9/21/00 the outcome of the event is ongoing.
Narrative: Patient received his first dose of the moderna COVID-19 immunization and reported that he developed a rash on his abdomen. He states that he was evaluated by his non-Facility provider, who prescribed prednisone for treatment of the rash and recommended not to receive the 2nd dose of the series.
Information has been received from a company representative, as told by the patient's mother, concerning an 11 year old female who on 15-MAR-2008 was vaccinated with her third dose of GARDASIL (lot# not reported). There was no concomitant medication. On 15-MAR-2008 the patient started sneezing which lasted for 4 days. Subsequently, the patient recovered from sneezing. The mother gave the patient BENADRYL, but it did not help. The patient sought unspecified medical attention. No further information is available.
Case number PHEH2014US020437, is an initial spontaneous report from a medical assistant received on 08 OCT 2014. This report refers to a 3 months old female neonate. Past medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 1411401) intramuscularly on 06 OCT 2014. On 07 OCT 2014, the patient began experiencing burning down the left side of her body and it was reported almost her body was warm. Outcome of the events was reported as ongoing at the time of this report. Seriousness and causality of the event was not reported.
No immediate adverse effects. About 2 hours after I received the vaccine, I began to experience noticeable pain/tenderness in my left bicep that slowly progressed throughout the evening. The next morning I was experiencing significant lethargy, body aches, headache, and extreme systemic skin sensitivity - even brushing my hair was painful. Those symptoms mostly resolved after 24 hours, and my arm is still slightly swollen and painful, but I've now developed a localized rash around the injection site.
started out with heat flashes and stomach nausea progressed into dry heaves with severe body aching in upper torso and massive headache for 2 days straight no fever. GlaxoSmith kline poisened my body as far as I am concerned. This shit almost killed me and I will be writing a letter to the manufacturer expressing my concerns and seeking 2 days worth of lost wages and for unknown damage to my body at this time.
Nausea, dry heaves, yellow matter in eyes for three days after vaccination, awaking in the morning.
A non-serious, spontaneous report of fever, sore throat and cough was received from a nurse concerning a nine-year-old male patient subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 30-Sep-2009 for an unknown indication. On the morning of 02-Oct-2009 the patient experienced a fever of 101.1 degrees Fahrenheit, sore throat and cough. No additional details were provided. The outcome for the reported adverse events was not reported.
14 year old patient got moderna as her first covid vaccine dose. Age breach was not identified until after patient got vaccine.
Pain in his arm; Fever (at night); Tiredness; Shivers; Headache; This is a spontaneous report from a contactable consumer (patient himself). An 81-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not experience symptoms until yesterday (after getting wet in the rain): pain in his arm, fever (at night), tiredness, shivers, headache in Jan2021. He chose not to go out of his house yesterday and today he felt better, only headache persists. Caller also reported it was cold outside and he was not sure if his symptoms were associated to the Pfizer-BioNTech COVID-19 vaccine, or symptoms of a cold (probably caused by exposure to rain and cold). Outcome of headache was not recovered, and outcome of other events was recovering.   Information on the lot/batch number has been requested.
White blood cell count almost doubled one month after the second vaccine and nearly tripled 6 weeks after the second vaccine.  Patient was placed on hospice on April 23rd and passed away on May 8th.
Inappropriate schedule of vaccine administered; Revaccination with different COVID-19 vaccine; interchange of vaccine products; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) and NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
PRESENTED TO ER WITH RUNNY NOSE, COUGH, SHORTNESS OF BREATH AND LOSS OF TASTE AND SMELL.  HE WAS ADMITTED TO THE MEDICAL CENTER ON 8/16/2021 WITH COVID-19, VIRAL PNEUMONIA AND RESPIRATORY FAILURE. HE CLAIMS TO HAVE HAD THE J&J VACCINE ON 7/28/21, BUT THERE IS NO RECORD OF IT. HE HAD CONTACT WITH HIS CHILDREN WHO ARE ALL COVID-19 POSITIVE
The resident developed COVID 19 Symptoms on 4/27/2021 and tested Positive for COVID 19 through POC and PCR testing.  Congestion and Diarrhea were the main symptoms.
Raised welty rash (itching, inflamed) 6" width on inner thigh and hip and inner elbow.
Sneezing; Running nose; Flu like symptom; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), RHINORRHOEA (Running nose) and INFLUENZA LIKE ILLNESS (Flu like symptom) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M208) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Running nose) and INFLUENZA LIKE ILLNESS (Flu like symptom). At the time of the report, SNEEZING (Sneezing), RHINORRHOEA (Running nose) and INFLUENZA LIKE ILLNESS (Flu like symptom) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Acute torticollis; This spontaneous case was reported by a consumer and describes the occurrence of TORTICOLLIS (Acute torticollis) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced TORTICOLLIS (Acute torticollis). At the time of the report, TORTICOLLIS (Acute torticollis) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported
Four to five itchy red medium-sized hives that appeared on my back around 2 hours after the vaccine was administered. Resolved following administration of Zyrtec 10mg PO.
Information has been received from a consumer concerning her daughter, an 18 year old female patient who on 09-FEB-2007 was vaccinated with the first dose of Gardasil. The caller reported that on 10-FEB-2007, her daughter "had a TB test administered. "On 22-FEB-2007 the patient experienced fever and flu-like symptoms. The patient sought unspecified medical attention. Additional information is not expected.
Dad was feeding baby. Baby went stiff then started shaking (arms and legs). Eyes rolled back in head and she was foaming at the mouth.
the baby threw up and could not take any additional doses; when the vaccine was administered, the baby threw up; This spontaneous report was received from a medical assistant and refers to an infant patient of unknown gender. The patient had existing issue with swallowing. No information on patient's medical history and current conditions was provided.      On an unknown date the patient was vaccinated with first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis (exact dose, route of administration, lot# and expiration date were not provided) (accidental underdose).         On an unknown date the patient experienced vomiting. The outcome of vomiting was unknown. Action taken with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) regarding the event was not applicable.  The causality between rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and the event was not provided.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2012, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. In 2015, the patient was treated by a physician at the Hospital Center for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
Arm is swollen, red blotches along the bicep and tricep areas. Blotches are also under the arm and up the chest. Patient also reports red circles.
The first 2 days I was very tired, but that went away.  1 week later my deltoid muscle felt firm and itched for several days.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Oct2022 as dose 5 (booster), single (Lot number: GH9703), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "elevated kidney numbers" (unspecified if ongoing), notes: other medical history: elevated kidney numbers; "atrial fibrillation" (unspecified if ongoing), notes: other medical history: atrial fibrillation. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Dec2022, outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Dec2022) Positive; (01Jan2023) Negative; (07Jan2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No known allergies reported. Other medication in 2weeks product was expectorant and cough suppressant from 25Dec2022 to 27Dec2022. Adverse event: experienced mild covid symptoms on 25Dec. Tested positive 27Dec. Began Paxlovid (renal dose) on 27Dec. Covid symptoms completely gone 30Dec. Tested negative 01Jan2023. Mild symptoms returned 04Jan2023. Tested positive for covid 07Jan2023.
Fever, headache, joint aches, fatigue, loss of appetite, chills,  sweats, loose bowels, 24 hours post vaccine; went away for about 48 hours.  Two days post vaccine, noted red, blotchy rash, somewhat pruritic around injection site.  One day later, original side effects returned for another day.  Rash color lessening over several days. Felt "as if hit by a truck". Only treatment was to take in extra fluids. Feeling mostly normal now at 6 days post vaccine.